Day: June 17, 2021

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND OR THE UNITED STATES OF AMERICA, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. Press Release 17 June 2021 Immunicum Announces Results of Directed Share Issue Immunicum AB (publ) (Nasdaq Stockholm: IMMU) (“Immunicum” or the “Company”) today announces that it has successfully completed a directed share issue of 33,233,433 shares at a subscription price of SEK 4.25 per share (the “Directed Issue”), through which the Company receives approximately SEK 141.2 million in gross proceeds, before deducting the commissions and estimated Directed Issue expenses payable by Immunicum. The board of...

FLORHAM PARK, N.J., June 17, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotechnology” or the “Company”), a clinical-stage immunotherapy company developing a pipeline of novel cancer therapies based on the Company’s proprietary Versamune® T-cell activating technology, today announced the closing of its previously announced underwritten public offering of 6,088,235 shares of common stock (inclusive of the 794,117 shares that were sold pursuant to the underwriter’s full exercise of its option to purchase additional shares of common stock) at a public offering price of $8.50 per share. Certain insiders, including certain members of the Company’s board of directors and executive officers, purchased shares of PDS Biotech common stock in the offering. The gross proceeds to PDS Biotech...

ATLANTA, June 17, 2021 (GLOBE NEWSWIRE) — Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” “the Company”, “we,” “our” or “us”), a technology-enabled financial services company, today announced that it has provided notice of redemption of all $16.5 million aggregate principal amount of its outstanding 5.875% convertible senior notes due 2035. The redemption date for the notes is July 19, 2021. The notes were issued pursuant to the terms of the Indenture, dated November 23, 2005, between the Company and U.S. Bank, as trustee. The notes are redeemable at a cash redemption price equal to 100% of the principal amount of the notes outstanding. Holders of the notes have the right to convert the notes called for redemption no later than 5:00 p.m., E.T. on July 16, 2021 for the consideration provided in the Indenture. This...

TORONTO and TAMPA, Fla., June 17, 2021 (GLOBE NEWSWIRE) — Voxtur Analytics Corp. (TSXV: VXTR; OTCQB: VXTRF) (“Voxtur” or the “Company”) announced today that Mr. Gary Yeoman, Executive Chairman, and Mr. Jim Albertelli, Chief Executive Officer, acquired 6,413,042 and 1,000,000 Restricted Share Units (“RSUs”) of the Company, respectively, on June 10, 2021. The Company further announced that Mr. Yeoman has sold 5,000,000 common shares of the Company as a block to strategic investors. The proceeds of this disposition will be used to settle taxes owed with respect to the vesting of RSUs held by Mr. Yeoman, and additionally to purchase a residence for the purpose of relocating to the United States. This relocation by Mr. Yeoman is intended to facilitate growth of the Company’s U.S. footprint in support of the Company’s strategic growth...

NEW YORK, June 17, 2021 (GLOBE NEWSWIRE) — BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced it will host a Research and Development (R&D) Day to discuss the development program for its novel immune agent, Plinabulin, in anti-cancer indications on Friday, June 25th, at 8:00 a.m. ET. The webinar will feature presentations by Key Opinion Leaders (KOLs) Steven Lin, M.D. (MD Anderson Cancer Center), and Trevor M. Feinstein, M.D. (Piedmont Cancer Institute), who will discuss the current treatment landscape and unmet medical need in treating patients with non-small cell lung cancer (NSCLC) and patients who failed checkpoint inhibitors. Drs. Lin and Feinstein will be available to answer questions following...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES (In Canadian Dollars unless otherwise stated) TORONTO, June 17, 2021 (GLOBE NEWSWIRE) — Cartier Iron Corporation (CSE:CFE) (“Cartier Iron” or the “Company”) is pleased to announce that due to investor demand in connection with its previously announced fully marketed private placement offering (the “Offering”), the Company and Cormark Securities Inc. (“Cormark”), who has agreed to act as an agent in connection with the Offering, have agreed to increase the size of the Offering to up to 16,666,667 units of the Company (the “Units”) at a price of $0.09 per Unit for gross proceeds of up to $1,500,000. The flow-through component of the Offering of up to 25,000,000 flow-through units of the Company (the “Flow-Through Units”,...

17 June 2021 LSE Code: 3HCS WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY(a public company incorporated with limited liability in Ireland)WISDOMTREE COPPER 3x DAILY SHORT SECURITIES ISIN: IE00B8KD3F05 RESULTS OF MEETING OF THE ETP SECURITYHOLDERS WisdomTree Multi Asset Issuer Public Limited Company (the “Issuer”) wishes to announce that the Extraordinary Resolution regarding the reduction in the principal amount of the WisdomTree Copper 3x Daily Short Securities (the “Affected Securities”) from USD 2 to USD 0.2, as set out in a notice to holders of the Affected Securities dated 30 April 2021, was passed at an adjourned meeting of the holders of the Affected Securities held at 11am on 17 June 2021. As a result, the Deed of Amendment has been duly executed by the Issuer, the Manager and the Trustee to put the proposed amendments to...